Acer Therapeutics

💊 Neuropharmaceuticals· 📍 Newton, MA, USA

Overview

Acer Therapeutics is a specialty pharmaceutical company focused on rare neurological and metabolic diseases, developing EDSIVOTM (sodium phenylbutyrate) for urea cycle disorders and other CNS conditions.

More in Neuropharmaceuticals

Cortexyme Inc.

San Francisco, CA, USA

Neuralstem Inc.

Germantown, MD, USA

Neurogenix Therapeutics

Basel, Switzerland

Acadia Pharmaceuticals

San Diego, USA

Praxis Precision Medicine

Cambridge, MA, USA

Axsome Therapeutics

New York, USA

Latest industry news

China Performs World's First Commercial BCI Implant, Marking a Pivotal Moment in the Global Brain-Computer Interface Race

2026-07-16 · Industry

NIH Confirms Brain-Computer Device Restores Speech in Human Patient

2026-07-15 · Research

Neurovalens Wins FDA Approval for Wearable PTSD Therapy Aimed at US Veterans

2026-07-14 · Policy

BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets

2026-07-13 · Funding

Company details

Is this your company?

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Claim & upgrade listing

Advertise

Reach neurotech professionals

Newsletter sponsorships, featured listings, and sponsored articles.

View packages →